论文部分内容阅读
广东天普生化医药股份有限公司:《广东天普生化医药股份有限公司发行H股于香港联合交易所创业板上市申请报告》、《关于广东天普生化医药股份有限公司修改股份面值拆细方案的豁免申请》及有关申请材料收悉。根据《中华人民共和国公司法》、《中华人民共和国证券法》、《国务院关于股份有限公司境外募集股份及上市的特别规定》等法律、法规的规定,经审核,现批复如下:一、同意你公司发行境外上市外资股
Guangdong Top Chemical & Biotech Co., Ltd.: “Report on the Application of H Shares Issuance by the Company to the Stock Exchange of Hong Kong on the Stock Exchange of Hong Kong”, “Proposal on Modification of the Par value of Shares by Guangdong Top Biochemical Co., Ltd. Exemption Application ”and the relevant application materials received. In accordance with the provisions of the Company Law of the People’s Republic of China, the Securities Law of the People’s Republic of China, the Special Regulations of the State Council on Overseas Offering of Shares and Listing Listed by Joint Stock Limited Companies and other laws and regulations, the following is approved: I. Agree with you The company issues overseas listed foreign shares